Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05599048 · ClinicalTrials.gov registry record · Phase 1

Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors

A Phase 1 study of Advanced Solid Tumor, sponsored by Robert Bok, MD, PhD.

Recruiting
Registry status
Phase 1
Development phase
65
Enrollment target
1
Study location

NCT05599048 is a Phase 1 study of Advanced Solid Tumor that is actively recruiting participants, run by Robert Bok, MD, PhD. The registered enrollment target is 65 participants, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05599048, a Phase 1 study of Advanced Solid Tumor, is actively recruiting participants, sponsored by Robert Bok, MD, PhD.

RECRUITING
Registry status
Phase 1
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

This is a single center prospective imaging study investigating the utility of hyperpolarized 13C-pyruvate +/-13C,15N-Urea/ metabolic MR imaging. The current protocol will serve as a companion imaging biomarker study paired with standard of care (SOC) therapeutics, as well as investigational therapies that participants may be scheduled to receive outside of this protocol.

Conditions Studied

Advanced Solid Tumor

Interventions

  • DRUG Hyperpolarized 13C-Pyruvate
  • PROCEDURE Magnetic Resonance Imaging (MRI)
  • DRUG 13C,15N-Urea

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2022-12-15
Est. Completion 2026-01-31
Phase Phase 1

Sponsor

Robert Bok, MD, PhD

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05599048

The ClinicalTrials.gov registry entry for NCT05599048 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (66% lower). The listed sponsor is Robert Bok, MD, PhD, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Solid Tumor appearing as the primary indexed condition, and to 3 interventions - of which Hyperpolarized 13C-Pyruvate is the first listed.

NCT05599048 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05599048 about?

NCT05599048 is a clinical study titled "Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors". This is a single center prospective imaging study investigating the utility of hyperpolarized 13C-pyruvate +/-13C,15N-Urea/ metabolic MR imaging. The current protocol will serve as a companion imaging biomarker study paired with standard of care (SOC) therapeutics, as well as investigational therapi...

What is the current status of trial NCT05599048?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 65 participants. The study started on 2022-12-15. Estimated completion is 2026-01-31.

What conditions does trial NCT05599048 study?

This clinical trial studies the following conditions: Advanced Solid Tumor.

What interventions are being tested in trial NCT05599048?

The interventions under investigation include: Hyperpolarized 13C-Pyruvate (DRUG), Magnetic Resonance Imaging (MRI) (PROCEDURE), 13C,15N-Urea (DRUG).

Who is sponsoring clinical trial NCT05599048?

This trial is sponsored by Robert Bok, MD, PhD, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05599048 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Solid Tumor

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.